ORIGIMED
OrigiMed is a medical science and technology transforming company which focuses on developing new technologies and clinical applications for all types of cancer patients. By carrying out more comprehensive and high-throughput methods, leveraging wholesome bioinformatics analysis and clinical annotation, they identify cancer specific molecular markers and genomic features to guide targeted or immuno-therapy, ultimately aiming to fortify the evolution of cancer precision medicine in China.
ORIGIMED
Social Links:
Industry:
Health Care Health Diagnostics
Founded:
2016-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.origimed.com
Total Employee:
251+
Status:
Active
Contact:
+86 400-821-9890
Email Addresses:
[email protected]
Total Funding:
39 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apache Mobile Non Scaleable Content Nginx Euro PHP PHP 7
Similar Organizations
CareDx
CareDx is a novel molecular diagnostics company.
Current Employees Featured
Founder
Investors List
Grand Flight Investment
Grand Flight Investment investment in Series B - OrigiMed
WeDo Capital Management
WeDo Capital Management investment in Series B - OrigiMed
StarVC
StarVC investment in Series A - OrigiMed
Volcanics Venture
Volcanics Venture investment in Angel Round - OrigiMed
IDG Capital
IDG Capital investment in Angel Round - OrigiMed
WeDo Capital Management
WeDo Capital Management investment in Angel Round - OrigiMed
Official Site Inspections
http://www.origimed.com
- Host name: 180.169.5.67
- IP address: 180.169.5.67
- Location: Shanghai China
- Latitude: 31.0449
- Longitude: 121.4012
- Timezone: Asia/Shanghai
More informations about "OrigiMed"
OrigiMed - Crunchbase Company Profile & Funding
OrigiMed is a medical science and technology transforming company which focuses on developing new technologies and clinical applications for all types …See details»
Origimed
OrigiMed announced that the Human NTRK1/2/3 Genomic Alteration Testing... Industry. 08 16. 至本医疗荣膺「VB100数字医... 近日，至本医疗凭借其数字疗法案例《数据驱动下的肿瘤智慧医疗创新平台》，成功入选动脉网「2021VB100 …See details»
About us - Origimed
OrigiMed is a leading data driven precision medicine company based in China. Our laboratories are CLIA certified and CAP accredited. We offer one stop customized solutions for all your precision oncology needs. We are involved in …See details»
OrigiMed
OrigiMed announ... OrigiMed Co., Ltd. ("OrigiMed") announced that the company has signed ... Industry. 08 22. The NGS based C... OrigiMed announced that the Human NTRK1/2/3 …See details»
OrigiMed Company Profile | Management and Employees List
OrigiMed collaborates with hospitals and institutes by providing comprehensive genomic testing in our CLIA-certificated and CAP-accredited laboratory. Its business covers over 40 cities in …See details»
OrigiMed Company Profile 2024: Valuation, Funding & Investors
OrigiMed General Information Description. Developer and researcher of new technologies and clinical application for cancer patients. The company conducts more comprehensive high …See details»
OrigiMed - Org Chart, Teams, Culture & Jobs - The Org
View OrigiMed's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
OrigiMed - Company Profile - Tracxn
Dec 10, 2024 OrigiMed. has raised a total funding of $10M over 4 rounds. What are the most recent funding rounds of OrigiMed? Its latest funding round was a Series B round on Jan 03, …See details»
OrigiMed | VentureRadar
OrigiMed is a medical science and technology transforming company which focuses on developing new technologies and clinical applications for all types of cancer patients. By …See details»
OrigiMed - Contacts, Employees, Board Members, Advisors
OrigiMed provides molecular diagnostic information for cancer patient.See details»
OrigiMed Company Profile - Office Locations, Competitors ... - Craft
OrigiMed has 5 employees at their 1 location. See insights on OrigiMed including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
OrigiMed - Overview, News & Similar companies | ZoomInfo.com
OrigiMed announced its strategic partnership with Janssen to develop clinical innovative solutions driven by data science SHANGHAI, Dec. 3, 2021 /PRNewswire/ -- OrigiMed Co., Ltd. …See details»
OrigiMed - Products, Competitors, Financials, Employees, …
OrigiMed is a medical science and technology transforming company which focuses on developing technologies and clinical applications for all types of cancer patients. By carrying …See details»
OrigiMed - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead ... Grand Flight Investment: Dec 20, 2017: …See details»
Origimed
Origimed is a young and dynamic software engineering company. We assembled a high performing team of experts with a wide range of expertise and strong experience in the latest …See details»
OrigiMed - ASCO Annual 2024
OrigiMed is a leading medical technology company. Our business covers two major areas: personalized precision diagnosis and treatment, collaborations with pharmaceutical …See details»
Another Laboratory of OrigiMed Has Been Accredited by CAP
Recently, the College of American Pathologists (CAP) announced that Shanghai OrigiMed Clinical Laboratory has been accredited by CAP. CAP is internationally recognized as an authoritative …See details»
OrigiMed enhances R&D in precision medicine to tap booming …
Aug 3, 2021 Shanghai-based OrigiMed, a leading precision medicine company. [Photo/OrigiMed] China's precision medicine sector shows great potential, as it accelerates the …See details»
Our Culture - Origimed
Contact address. 5th Floor, Building 3, 115 Xinjun Ring Road, Minhang District, Shanghai. Floor 4, Information Building 2, Zhaolou Road 3576 , Pujiang Town, Minhang ...See details»
News - Origimed
OrigiMed Showcases Latest Research Findings at the 2024 ESMO . 2024-09-11 . Click for More Details. 2024 ASCO | Deepening Pharmaceutical Collaboration, Accelerating Drug …See details»